Paul Sagan - Oct 13, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Director
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Oct 13, 2021
Transactions value $
-$708,525
Form type
4
Date filed
10/15/2021, 04:03 PM
Previous filing
Aug 13, 2021
Next filing
May 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Sale -$709K -2.25K -13.08% $314.90 15K Oct 13, 2021 By: Erwin Park LLC F1, F2
holding MRNA Common Stock 76.5K Oct 13, 2021 By: The Chatham Trust F2
holding MRNA Common Stock 370K Oct 13, 2021 By: The Paul Sagan Revocable Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2021.
F2 Erwin Park LLC is an estate planning vehicle for the Reporting Person's family. The Chatham Trust is an irrevocable family trust for which the Reporting Person serves as a trustee. The Paul Sagan Revocable Trust is a revocable trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.